… Benign thyroid nodules are very common, whereas clinically detectable thyroid cancer is
relatively rare. Accordingly, a selective approach to the management of thyroid nodules is …

… evaluates a policy of selective limited thyroidectomy and postoperative radioiodine ablation
based on risk stratification of patients for management of differentiated thyroid cancers. It has …

… This article analyzes in depth our data on low-risk thyroid cancer patients. … Four hundred
three patients had papillary and 62 patients had follicular thyroid cancer. There were 120 male …

… treatment for radioactive iodine-refractory advanced and progressive differentiated thyroid
cancer. … second approved MKI for advanced differentiated thyroid cancer, or include patients in …

… thyroid cancer (FTC) and in half of anaplastic thyroid cancer (ATC) and poorly differentiated
thyroid cancer (PDTC), while they are present in only 10%–15% of papillary thyroid cancer (…

… In recent years, a growing body of evidence has improved our understanding of radioactive
iodine (RAI) as a treatment for patients with thyroid cancer. The therapeutic ratio by which …

… The entire idea of selective surgical treatment rests on understanding the biology of the …
cancer, not over-treating every patient with thyroid cancer, and using adjuvant therapy selectively…

… addition to the existing treatment of selected cases of thyroid cancer in the present study, the
usefulness of SETA was evaluated as a pretreatment to thyroid surgery in selected cases of …

… 3 important topics in thyroid cancer management: the option of thyroid lobectomy as initial
… the selective use of radioactive iodine for remnant ablation, adjuvant treatment, or treatment …

… promising results in the treatment of metastatic MTC resistant to non-selective TKIs. The
FDA… has revolutionized treatment of BRAF V600E mutation positive anaplastic thyroid cancer. …